Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00959 |
B7-2 Protein, Rabbit, Recombinant (His)
CD86,T-lymphocyte ac... |
Rabbit | HEK293 Cells |
B7-2 Protein, Rabbit, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 38-70 KDa and the accession number is P42071. | |||
TMPJ-00632 |
B7-2 Protein, Cynomolgus, Recombinant (hFc)
T-lymphocyte activation ... |
Cynomolgus | HEK293 Cells |
B7-2 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 70-100 KDa and the accession number is G7NXR4. | |||
TMPJ-00641 |
B7-2 Protein, Rhesus macaque, Recombinant (His)
Activation B7-2 antigen,T |
Rhesus | HEK293 Cells |
B7-2 Protein, Rhesus macaque, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 40-90 KDa and the accession number is H9ZFI8. | |||
TMPJ-00555 |
B7-2 Protein, Human, Recombinant (Avi & His), Biotinylated
Activation B7-2 Antigen,FUN-1,C |
Human | HEK293 Cells |
B7-2 Protein, Human, Recombinant (Avi & His), Biotinylated is expressed in HEK293 mammalian cells with C-Avi-6xHis tag. The predicted molecular weight is 55-80 KDa and the accession number is AAH40261.1. | |||
TMPJ-00556 |
B7-2 Protein, Human, Recombinant (His)
CD86,T-Lymphocyte Ac... |
Human | HEK293 Cells |
B7-2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 57-66 KDa and the accession number is AAH40261.1. | |||
TMPK-00112 |
CTLA-4 Protein, Human, Recombinant (His & Avi), Biotinylated
IDDM12,ICOS,CD152,GRD4,CTLA4,CELIAC3,GSE,A... |
Human | HEK293 Cells |
CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), also known as CD152, is a protein receptor that, functioning as an immune checkpoint, downregulates immune responses.CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation – a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells. |